Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (129)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Catenacci, DanielPerson Why?
Gastroesophageal cancer: focus on epidemiology, classification, and staging.Academic Article Why?
Quality of Life, Symptoms, and Self-Management Strategies After Gastroesophageal Cancer Surgery.Academic Article Why?
Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design.Academic Article Why?
Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.Academic Article Why?
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.Academic Article Why?
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.Academic Article Why?
Biomarker testing for breast, lung, and gastroesophageal cancers at NCI designated cancer centers.Academic Article Why?
Gastroesophageal reflux disease: From heartburn to cancer.Academic Article Why?
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.Academic Article Why?
For Gastroesophageal Junction Cancers, Does an "Esophageal" or "Gastric" Surgical Approach Offer Better Perioperative and Oncologic Outcomes?Academic Article Why?
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.Academic Article Why?
Antireflux surgery for dysplastic Barrett.Academic Article Why?
Role of minimally invasive surgery in the modern treatment of Barrett's esophagus.Academic Article Why?
Eng, OliverPerson Why?
Per Page    Page  of 9last Nextnext
Prev
Search Criteria
  • Gastroesophageal
  • Cancer
Filter by Type